16.0 |
48.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
10.4 |
41.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
10.1 |
30.3 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
10.0 |
49.8 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
8.7 |
52.0 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
7.7 |
38.3 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
7.4 |
22.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
7.4 |
66.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
7.3 |
36.3 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
7.1 |
42.5 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
6.5 |
103.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
6.0 |
35.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
5.8 |
46.7 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.7 |
28.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
5.5 |
60.2 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
5.4 |
48.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
5.3 |
15.9 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
5.3 |
26.5 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
4.9 |
14.8 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) noradrenergic neuron differentiation(GO:0003357) |
4.7 |
18.9 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
4.3 |
17.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
4.3 |
17.3 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
4.2 |
20.8 |
GO:0032763 |
regulation of mast cell cytokine production(GO:0032763) |
4.1 |
12.4 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
4.0 |
8.0 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
3.9 |
7.8 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
3.9 |
38.9 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
3.9 |
38.6 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
3.7 |
25.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
3.6 |
14.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.5 |
14.1 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
3.5 |
45.5 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
3.5 |
24.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
3.5 |
10.4 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.4 |
144.3 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
3.4 |
20.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
3.4 |
10.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
3.3 |
40.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
3.3 |
110.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
3.2 |
48.3 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
3.1 |
9.4 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
3.0 |
9.0 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
2.9 |
11.7 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
2.9 |
11.5 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
2.8 |
28.1 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
2.8 |
33.5 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
2.8 |
47.0 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
2.7 |
38.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
2.7 |
59.4 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.6 |
13.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.6 |
7.9 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
2.6 |
5.2 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
2.6 |
10.4 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
2.6 |
7.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
2.6 |
12.9 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
2.6 |
33.5 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
2.6 |
15.3 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
2.5 |
5.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
2.4 |
19.4 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.4 |
7.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
2.4 |
28.4 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
2.3 |
23.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
2.3 |
15.9 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.3 |
9.1 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.2 |
6.7 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
2.2 |
15.6 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
2.2 |
8.7 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
2.1 |
10.5 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
2.1 |
14.5 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
2.1 |
8.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
2.0 |
11.9 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
1.9 |
11.6 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.9 |
9.6 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
1.9 |
7.7 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
1.9 |
9.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.9 |
3.8 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
1.8 |
24.0 |
GO:0070842 |
aggresome assembly(GO:0070842) |
1.8 |
5.5 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
1.8 |
5.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
1.8 |
57.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
1.8 |
8.8 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
1.7 |
7.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
1.7 |
10.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.7 |
13.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
1.6 |
20.9 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.5 |
7.5 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
1.5 |
4.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.5 |
1.5 |
GO:0097324 |
melanocyte migration(GO:0097324) |
1.5 |
33.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
1.4 |
14.2 |
GO:0007379 |
segment specification(GO:0007379) |
1.4 |
4.3 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.4 |
8.4 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.4 |
7.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
1.4 |
49.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
1.4 |
19.0 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
1.4 |
5.4 |
GO:0007412 |
axon target recognition(GO:0007412) |
1.4 |
12.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.3 |
16.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
1.3 |
5.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
1.3 |
7.8 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.3 |
5.2 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
1.3 |
2.6 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.3 |
14.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
1.3 |
3.8 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
1.3 |
17.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
1.2 |
3.7 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
1.2 |
3.6 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
1.2 |
2.4 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
1.1 |
13.7 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.1 |
18.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
1.1 |
38.6 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.1 |
17.0 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
1.1 |
2.2 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
1.1 |
5.5 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 |
5.5 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
1.1 |
8.6 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
1.1 |
6.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
1.1 |
26.5 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
1.0 |
3.1 |
GO:0010881 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.0 |
2.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.0 |
7.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.0 |
5.9 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
1.0 |
13.8 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
1.0 |
21.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
1.0 |
2.9 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.9 |
2.8 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
0.9 |
3.7 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
0.9 |
3.6 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.9 |
13.5 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.9 |
5.3 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.9 |
6.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
0.8 |
2.5 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
0.8 |
3.2 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 |
14.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.8 |
47.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.8 |
32.5 |
GO:0021766 |
hippocampus development(GO:0021766) |
0.8 |
35.3 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
0.8 |
5.5 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.8 |
1.5 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.8 |
28.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
0.8 |
1.5 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.8 |
9.8 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
0.7 |
3.0 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.7 |
4.5 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 |
3.0 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.7 |
8.1 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
0.7 |
3.7 |
GO:0030242 |
pexophagy(GO:0030242) |
0.7 |
1.5 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.7 |
2.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.7 |
2.1 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 |
2.7 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
0.7 |
53.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.7 |
2.7 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
0.7 |
6.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.7 |
1.3 |
GO:0051026 |
chiasma assembly(GO:0051026) |
0.6 |
3.2 |
GO:0032911 |
neurotrophin production(GO:0032898) nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 |
4.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.6 |
3.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
0.6 |
2.6 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.6 |
5.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.6 |
5.6 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.6 |
1.3 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.6 |
3.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
0.6 |
6.8 |
GO:0001553 |
luteinization(GO:0001553) |
0.6 |
1.8 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
0.6 |
4.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
0.6 |
2.4 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.6 |
3.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 |
26.1 |
GO:0008542 |
visual learning(GO:0008542) |
0.6 |
1.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.6 |
2.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 |
10.7 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.6 |
3.9 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
0.5 |
3.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
0.5 |
7.1 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.5 |
3.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.5 |
1.6 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
0.5 |
5.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 |
3.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
0.5 |
4.6 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
0.5 |
1.5 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 |
0.5 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 |
3.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 |
2.5 |
GO:0036438 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) maintenance of lens transparency(GO:0036438) |
0.5 |
2.5 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.5 |
9.9 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
0.5 |
1.5 |
GO:2000822 |
regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.5 |
2.0 |
GO:0051012 |
microtubule sliding(GO:0051012) |
0.5 |
7.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
0.5 |
2.0 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 |
7.8 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
0.5 |
4.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
0.5 |
1.4 |
GO:0060613 |
fat pad development(GO:0060613) |
0.5 |
1.9 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 |
4.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.5 |
29.6 |
GO:0007612 |
learning(GO:0007612) |
0.5 |
41.9 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.5 |
0.9 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
0.5 |
1.8 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 |
1.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
0.5 |
1.8 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.5 |
4.5 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
0.4 |
14.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 |
3.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
0.4 |
1.3 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
0.4 |
2.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.4 |
0.9 |
GO:0060023 |
soft palate development(GO:0060023) |
0.4 |
13.1 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
0.4 |
8.4 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.4 |
7.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 |
2.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
0.4 |
3.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 |
23.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 |
1.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
0.4 |
3.0 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
0.4 |
8.1 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 |
0.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 |
1.8 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
0.4 |
3.2 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
0.4 |
1.8 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
0.4 |
7.5 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 |
1.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
0.4 |
2.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
0.4 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 |
3.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 |
2.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.3 |
1.4 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.3 |
13.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
0.3 |
1.7 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 |
3.8 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
0.3 |
3.4 |
GO:2001256 |
behavioral response to cocaine(GO:0048148) regulation of store-operated calcium entry(GO:2001256) |
0.3 |
3.0 |
GO:0030325 |
adrenal gland development(GO:0030325) |
0.3 |
4.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
0.3 |
1.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 |
3.3 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
0.3 |
5.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
0.3 |
0.7 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 |
1.3 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 |
1.3 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
0.3 |
2.2 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
0.3 |
1.2 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
0.3 |
1.8 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
0.3 |
4.5 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.3 |
3.3 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
0.3 |
4.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
0.3 |
0.6 |
GO:1903044 |
protein localization to plasma membrane raft(GO:0044860) protein localization to membrane raft(GO:1903044) regulation of establishment of T cell polarity(GO:1903903) |
0.3 |
1.4 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 |
1.4 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.3 |
9.7 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
0.3 |
1.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.3 |
2.2 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
0.3 |
1.6 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 |
0.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
0.3 |
6.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
0.3 |
1.6 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.3 |
3.1 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 |
1.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 |
16.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
0.3 |
2.8 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
0.2 |
2.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
0.2 |
10.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.2 |
2.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
0.2 |
2.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
0.2 |
4.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
0.2 |
2.6 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
0.2 |
2.6 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
0.2 |
1.2 |
GO:1902459 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) positive regulation of stem cell population maintenance(GO:1902459) |
0.2 |
2.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
0.2 |
3.9 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 |
0.5 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
0.2 |
0.7 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 |
2.0 |
GO:0031272 |
regulation of pseudopodium assembly(GO:0031272) |
0.2 |
3.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.2 |
1.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 |
1.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
0.2 |
1.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.2 |
2.1 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 |
1.4 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
0.2 |
1.6 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
0.2 |
1.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
0.2 |
0.8 |
GO:0006953 |
acute-phase response(GO:0006953) |
0.2 |
0.6 |
GO:0042701 |
progesterone secretion(GO:0042701) |
0.2 |
0.8 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) taurine metabolic process(GO:0019530) |
0.2 |
4.6 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
0.2 |
0.6 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 |
0.6 |
GO:0015793 |
glycerol transport(GO:0015793) |
0.2 |
2.6 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
0.2 |
1.7 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 |
0.2 |
GO:2000778 |
positive regulation of interleukin-6 secretion(GO:2000778) |
0.2 |
1.6 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
0.2 |
10.1 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 |
0.7 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 |
1.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
0.2 |
0.7 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
0.2 |
1.0 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
0.2 |
0.8 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.2 |
1.0 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
0.2 |
2.2 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 |
3.3 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
0.2 |
15.6 |
GO:0098792 |
xenophagy(GO:0098792) |
0.2 |
5.2 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
0.2 |
1.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
0.2 |
1.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 |
0.5 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 |
1.4 |
GO:0002021 |
response to dietary excess(GO:0002021) |
0.2 |
1.7 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
0.2 |
0.5 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 |
1.0 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
0.1 |
1.9 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
0.1 |
2.5 |
GO:0002931 |
response to ischemia(GO:0002931) |
0.1 |
7.6 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
0.1 |
0.8 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
0.1 |
2.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.1 |
2.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.1 |
1.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 |
0.9 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
0.1 |
5.8 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 |
14.7 |
GO:0006813 |
potassium ion transport(GO:0006813) |
0.1 |
2.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
0.1 |
0.8 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
0.1 |
1.9 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 |
0.7 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
0.1 |
0.8 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
0.1 |
0.5 |
GO:0051684 |
SNARE complex assembly(GO:0035493) maintenance of Golgi location(GO:0051684) |
0.1 |
1.4 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 |
0.8 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
0.1 |
2.1 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
0.1 |
1.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
0.1 |
1.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
0.1 |
2.2 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
0.1 |
0.9 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.1 |
3.7 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
0.1 |
0.7 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
0.1 |
12.4 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
0.1 |
6.6 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
0.1 |
6.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.1 |
1.1 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 |
0.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.1 |
2.8 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
0.1 |
7.4 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
0.1 |
0.6 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.1 |
1.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.1 |
0.7 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
0.1 |
5.8 |
GO:0031929 |
TOR signaling(GO:0031929) |
0.1 |
0.3 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
0.1 |
0.8 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.1 |
1.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 |
0.8 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
0.1 |
1.1 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
0.1 |
0.2 |
GO:0021548 |
pons development(GO:0021548) cochlear nucleus development(GO:0021747) cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 |
0.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 |
0.7 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 |
2.5 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
0.1 |
0.4 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 |
2.5 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
0.1 |
0.2 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
0.1 |
0.5 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 |
1.0 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
0.1 |
1.7 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 |
0.5 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 |
0.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.1 |
1.6 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 |
2.0 |
GO:0016575 |
histone deacetylation(GO:0016575) |
0.1 |
1.4 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
0.0 |
0.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 |
0.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.0 |
1.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
0.0 |
0.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
0.0 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 |
2.0 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
0.0 |
0.4 |
GO:0070131 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) positive regulation of mitochondrial translation(GO:0070131) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 |
0.1 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 |
0.4 |
GO:0007032 |
endosome organization(GO:0007032) |
0.0 |
0.1 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
0.0 |
1.3 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
0.0 |
0.6 |
GO:0010659 |
cardiac muscle cell apoptotic process(GO:0010659) |
0.0 |
0.6 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
0.0 |
0.2 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 |
0.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
0.0 |
0.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
0.0 |
0.1 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 |
0.4 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
0.0 |
0.2 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 |
0.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
0.0 |
0.6 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |